Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

Transgene

Founders Pierre Chambon

Overview

Investments

Unlock datapoints

Portfolio analytics

Team

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.

Need help with fundraising?

We offer an assisted fundraising option for startups

Learn more
Total investments 1
Average round size
info
The average size of a deal this fund participated in
$2M
Portfolio companies 1
Rounds per year 0.02
Lead investments 1
Key employees Soon
http://www.transgene.fr
Illkirch-graffenstaden, Alsace, France

Areas of investment

  • Therapeutics
  • Biotechnology
  • Health Care
Look at other 50 related and similar funds Collapse list ↓
Fund NameLocation
58.com Beijing, Beijing, China
Allos Therapeutics Colorado, United States, Westminster
Andurance Ventures England, London, United Kingdom
Circle Ventures New York, New York, United States
Dada Firenze, Italy, Toscana
Denham Capital Boston, Massachusetts, United States
Global Atlantic Atlanta, Georgia, United States
Hoop Partners -
Indiegogo California, San Francisco, United States
MEGA Holding Italy, Lombardy, Milan
Obvious Ventures California, San Francisco, United States
PAR Florida, Lutz, United States
Platform Partners Houston, Texas, United States
Prologis Ventures California, San Francisco, United States
R-H Capital Partners California, San Diego, United States
Regiment Capital Boston, Massachusetts, United States
Ruizheng Investment -
Sarwa Capital Al Qahirah, Cairo, Egypt
The Kuok Group Johor, Johor Bahru, Malaysia
Venture Tech Associates -

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

ElsaLys Biotech

Biotechnology
Health Care
Therapeutics
$2M17 May 2013
Transgene
Sofimac Partners
 Auvergne-Rhône-Alpes
By posting comments on our website you confirm and acknowledge that:

1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.

2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.

3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.

4. We can moderate comments at any time.

5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.

6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.

Agree

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Transgene?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!
Total investments 1
Average round size 2M
Rounds per year 0.02
Peak activity year 2013
Lead investments 1
Group Appearance index 1.00

Latest deals

CompanyIndustryRound SizeDateInvestorsLocation

ElsaLys Biotech

Biotechnology
Health Care
Therapeutics
$2M17 May 2013
Transgene
Sofimac Partners
 Auvergne-Rhône-Alpes
Crunchbase icon

Content report

The following text will be sent to our editors:

Send